20 (AIDX) Payables (2024 - 2026)

20 posted quarterly Payables of $1.3 million for Q1 2026, up 42.22% on a QoQ basis from $943156.0 in Q4 2025.

20 (AIDX) has 3 years of Payables data on file, last reported at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Payables changed N/A year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (changed N/A YoY), and the FY2025 full-year result was $943156.0, up 153.33% from the prior year.
  • Payables for Q1 2026 stood at $1.3 million, up from $943156.0 in the prior quarter.
  • Across five years, Payables topped out at $1.3 million in Q1 2026 and bottomed at $372303.0 in Q4 2024.
  • The 3-year median for Payables is $943156.0 (2025), against an average of $885617.7.
  • Peak annual rise in Payables reached 153.33% in 2025, while the deepest fall reached 153.33% in 2025.
  • A 3-year view of Payables shows it stood at $372303.0 in 2024, then jumped by 153.33% to $943156.0 in 2025, then soared by 42.22% to $1.3 million in 2026.
  • The last three Payables figures came in at $1.3 million (Q1 2026), $943156.0 (Q4 2025), and $372303.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 5.78 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 2.57 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 181.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.74 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.07 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.42 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 457.70 Mn
10 20 - - 62,884.00 1.34 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.34 Mn
Dec 31, 2025 943,156.00
Dec 31, 2024 372,303.00